SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech & Nutrition informs about trading window closure

30 Mar 2026 Evaluate
Emmessar Biotech & Nutrition has informed that pursuant to clause 4 of the Schedule B of SEBI Prohibition of Insider Trading Regulations, 2015 (SEBI (PIT)) as amended, the Trading Window for dealing in the securities of the Company, will remain closed with effect from April 01, 2026 till the end of 48 hours after the financial results of the Company for the financial year and quarter ending March 31, 2026, become generally available information.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

25.30 -0.62 (-2.39%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×